Bronchiectasis in Older Patients with Chronic Obstructive Pulmonary Disease

Whitters, Deborah; Stockley, Robert
April 2013
Drugs & Aging;2013, Vol. 30 Issue 4, p215
Academic Journal
The prevalence of chronic obstructive pulmonary disease (COPD) increases with age. Recent evidence suggests that the finding of co-existent bronchiectasis is becoming increasingly common, possibly because of increased use of high-resolution CT scanning in the assessment of patients with COPD. This may represent a distinct phenotype of COPD, but, nevertheless, it is likely to pose an increased burden to health services and challenges in determining the correct management of these patients. Here, we review the factors associated with bronchiectasis in older patients with COPD and the evidence for many of the therapies currently used in the treatment of patients, providing a rational approach to their management.


Related Articles

  • EDITORS' CHOICE. Stephenson, Paul; Sheikh, Aziz // Primary Care Respiratory Journal;Jun2011, Vol. 20 Issue 2, p1 

    An introduction is presented in which the editorsdiscuss various reports within the issue on topics including optimal care for chronic obstructive pulmonary disease (COPD) patients, written asthma action plans and bronchiectasis diagnosis.

  • The Saudi guidelines for chronic obstructive pulmonary disease: A fresh "Real-World" approach to COPD. Hanania, Nicola A. // Annals of Thoracic Medicine;Apr-Jun2014, Vol. 9 Issue 2, p53 

    The article discusses the development of an evidence-based clinical practice guidelines for patients with chronic obstructive pulmonary disease (COPD), which was started by the Saudi Thoracic Society (STS) Initiative for Chronic Airways Diseases (SICAD). Topics include the recommendations to use...

  • The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease. Diar Bakerly, Nawar; Woodcock, Ashley; New, John P.; Gibson, J. Martin; Wei Wu; Leather, David; Vestbo, Jørgen // Respiratory Research;9/4/2015, Vol. 16 Issue 1, p1 

    Background: New treatments need to be evaluated in real-world clinical practice to account for co-morbidities, adherence and polypharmacy. Methods: Patients with chronic obstructive pulmonary disease (COPD), ≥40 years old, with exacerbation in the previous 3 years are randomised 1:1 to...

  • Predictors of in-hospital mortality in patients with acute exacerbation of COPD requiring ventilation: a retrospective study. Wensen Pan; Jing Yu; Lili Zhang; Hongshen Yang; Yadong Yuan // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 11, p22093 

    Background: Previous studies sought to identify survival or outcome predictors in patients with chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation (MV), but their findings are inconsistent. This study aims to identify clinical predictors of in-hospital mortality among...

  • Trends in management and outcomes of COPD patients in primary care, 2000-2009: a retrospective cohort study. James, Gareth D.; Donaldson, Gavin C.; Wedzicha, Jadwiga A.; Nazareth, Irwin // Primary Care Respiratory Society UK;7/1/2014, p1 

    BACKGROUND: Since the introduction of the Quality and Outcomes framework, there has been some evidence of improvement in the management of chronic obstructive pulmonary disease (COPD) patients in the United Kingdom through increasing rates of smoking cessation advice and immunisations against...

  • COPD and disease-specific health status in a working population. Koichi Nishimura; Satoshi Mitsuma; Atsuko Kobayashi; Mikako Yanagida; Kazuhito Nakayasu; Yoshinori Hasegawa; Jones, Paul W. // Respiratory Research;Jun2013, Vol. 14 Issue 6, p1 

    Background: It has been debated whether treatment should be started early in subjects with mild to moderate COPD. An impaired health status score was associated with a higher probability of being diagnosed with COPD as compared with undiagnosed COPD. Purpose: To investigate the health status in...

  • COPD Phenotypes and Biomarkers: Introducing Personalised Medicine. Mathioudakis, Alexandros G.; Chatzimavridou-Grigoriadou, Victoria; Corlateanu, Alexandru; Mathioudakis, Georgios A.; M.A. Calverley, Peter // Current Respiratory Medicine Reviews;Dec2013, Vol. 9 Issue 6, p372 

    Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality worldwide. Disease severity evaluation was based on airflow limitation for many years. However, it is now obvious that no single parameter can describe the complexity of COPD and a more holistic approach...

  • On the web.  // Primary Health Care;Apr2012, Vol. 22 Issue 3, p12 

    The article reviews several web sites including the chronic obstructive pulmonary diseases (COPD) Assessment Test (CAT) online available at catestonline.co.uk and the global initiative for chronic obstructive lung disease (GOLD) available at www.goldcopd.org.

  • Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke–Induced COPD in C57BL/6 mice. Peron, Jean Pierre Schatzmann; de Brito, Auriléia Aparecida; Pelatti, Mayra; Brandão, Wesley Nogueira; Vitoretti, Luana Beatriz; Greiffo, Flávia Regina; da Silveira, Elaine Cristina; Oliveira-Junior, Manuel Carneiro; Maluf, Mariangela; Evangelista, Lucila; Halpern, Silvio; Nisenbaum, Marcelo Gil; Perin, Paulo; Czeresnia, Carlos Eduardo; Câmara, Niels Olsen Saraiva; Aimbire, Flávio; Vieira, Rodolfo de Paula; Zatz, Mayana; Ligeiro de Oliveira, Ana Paula // PLoS ONE;8/31/2015, Vol. 10 Issue 9, p1 

    Cigarette smoke-induced chronic obstructive pulmonary disease is a very debilitating disease, with a very high prevalence worldwide, which results in a expressive economic and social burden. Therefore, new therapeutic approaches to treat these patients are of unquestionable relevance. The use of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics